The influence of HLA matching and lymphocytotoxic antibody status in heart-lung allograft recipients receiving cyclosporin and azathioprine.
Festenstein
H
H
Harefield Hospital, Middlesex, Great Britain.
Banner
N
N
Smith
J
J
Awad
J
J
Burden
M
M
Fitzgerald
N
N
Holmes
J
J
Khaghani
A
A
Smith
J
J
McCloskey
D
D
D000017:ABO Blood-Group System; D001379:Azathioprine / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use*; D003601:Cytotoxicity Tests, Immunologic; D006085:Graft Survival / Q000187:drug effects; D006680:HLA Antigens / Q000032:analysis*; D015234:HLA-A Antigens / Q000032:analysis; D006684:HLA-DR Antigens / Q000032:analysis; D016027:Heart Transplantation; D016041:Heart-Lung Transplantation; D006650:Histocompatibility Testing; D006801:Humans; D016040:Lung Transplantation; D011379:Prognosis; D014184:Transplantation, Homologous
D000017:ABO Blood-Group System; D003524:Cyclosporins; D006680:HLA Antigens; D015234:HLA-A Antigens; D006684:HLA-DR Antigens; D001379:Azathioprine